Literature DB >> 8593082

The toxicity of organoarsenic-based warfare agents: in vitro and in vivo studies.

J Henriksson1, A Johannisson, P A Bergqvist, L Norrgren.   

Abstract

The four arsenic-containing chemical warfare agents (CWA) Adamsite (technical, 10-chloro-9-10-dihydrophenarsazine), Clark 1 (Diphenyl arsine chloride), Clark 2 (Diphenyl arsine cyanide), and Lewisite (2-chloro-ethenyl dichloro arsine) were evaluated toxicologically using an in vitro and an in vivo model. The CWA were tested in vitro, using human leucocytes, in order to evaluate their effects on cell proliferation and cell cycle kinetics assayed by flow cytometry. The concentration for total inhibition of cell proliferation for the CWAs ranged from 0.3 micrograms/mL (Lewisite) to 15 micrograms/mL (Clark 1). The results showed no differences in cell proliferation between the different stages of the S-phase either at no-effect or at effect concentrations when samples treated with the CWAs were compared with untreated controls. As2O5 was used as a reference, and the arsenic concentration required for total inhibition of the cell proliferation was 1.7 mg/mL. A lower arsenic concentration, 0.83 micrograms/mL, showed a decreasing proliferation ration in the different parts of the S-phase with Searly and Slate having the highest and lowest ratios, respectively. In addition, there was a positive correlation between the unlabeled S-phase cell ratio and the arsenic concentration, indicating cessation of DNA-synthesis. Conclusively, the examined CWAs exerts a toxicity more potent than arsenic, with respect to cell proliferation. This might indicate that the toxicity of these arsenic-containing CWAs only to a minor extent can be explained by their arsenic content. Because of their relatively good water solubility and ability to easily degrade to arsenic acid, organo-arsenics, e.g., Lewisite, pose less of an environmental threat than organo-arsenics that are sparingly soluble and chemically persistent, like Adamsite. The four CWAs were also tested in vivo in a dietary exposure study, using juvenile three-spined stickleback (Gasterosteus aculeatus L.) as test organism, with measurement of EROD-activity and studies of liver morphology. The results from the in vivo study indicated small effects, suggesting that a 10-week period of dietary exposure at tested dose levels (1 and 100 ng/ml) affects juvenile three-spined stickleback only to a minor extent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8593082     DOI: 10.1007/bf00215800

Source DB:  PubMed          Journal:  Arch Environ Contam Toxicol        ISSN: 0090-4341            Impact factor:   2.804


  8 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Arsenic accumulation, tissue distribution and cytotoxicity in teleosts following indirect aqueous exposures.

Authors:  E M Sorensen; R E Henry; R Ramirez-Mitchell
Journal:  Bull Environ Contam Toxicol       Date:  1979-01       Impact factor: 2.151

3.  Differential induction of cytochrome P-450-dependent monooxygenase, epoxide hydrolase, glutathione transferase and UDP glucuronosyl transferase activities in the liver of the rainbow trout by beta-naphthoflavone or Clophen A50.

Authors:  T Andersson; M Pesonen; C Johansson
Journal:  Biochem Pharmacol       Date:  1985-09-15       Impact factor: 5.858

4.  The ECITTS integrated toxicity testing scheme: The application of in vitro test systems to the hazard assessment of chemicals.

Authors:  B J Blaauboer; M Balls; V Bianchi; G Bolcsfoldi; A Guillouzo; G A Moore; L Odland; C A Reinhardt; H Spielmann; E Walum
Journal:  Toxicol In Vitro       Date:  1994-08       Impact factor: 3.500

5.  Mixed lymphocyte reactions evaluated by means of bromodeoxyuridine incorporation.

Authors:  A Bontadini; R Conte; A Dinota; D Belletti; C Tassi; P L Tazzari; M Gobbi
Journal:  Haematologica       Date:  1990 Jan-Feb       Impact factor: 9.941

6.  Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine.

Authors:  F Dolbeare; H Gratzner; M G Pallavicini; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

Review 7.  Screening of toxic compounds in mammalian cell cultures.

Authors:  B Ekwall
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

8.  Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells.

Authors:  M Tsurusawa; M Niwa; N Katano; T Fujimoto
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

  8 in total
  5 in total

Review 1.  Biological and environmental hazards associated with exposure to chemical warfare agents: arsenicals.

Authors:  Changzhao Li; Ritesh K Srivastava; Mohammad Athar
Journal:  Ann N Y Acad Sci       Date:  2016-09-16       Impact factor: 5.691

2.  Development of BRD4 inhibitors as anti-inflammatory agents and antidotes for arsenicals.

Authors:  Marina Fosso Yatchang; Bini Mathew; Ritesh K Srivastava; Jasim Khan; Suhail Muzaffar; Sixue Zhang; Mousheng Wu; Ling Zhai; Pedro Ruiz; Anupam Agarwal; James R Bostwick; Mark J Suto; Mohammad Athar; Corinne E Augelli-Szafran
Journal:  Bioorg Med Chem Lett       Date:  2022-03-19       Impact factor: 2.940

3.  Decomposition of phenylarsonic acid by AOP processes: degradation rate constants and by-products.

Authors:  K Jaworek; M Czaplicka; Ł Bratek
Journal:  Environ Sci Pollut Res Int       Date:  2014-05-15       Impact factor: 4.223

4.  Single-molecule analysis of chirality in a multicomponent reaction network.

Authors:  Mackay B Steffensen; Dvir Rotem; Hagan Bayley
Journal:  Nat Chem       Date:  2014-05-18       Impact factor: 24.427

5.  Defining cutaneous molecular pathobiology of arsenicals using phenylarsine oxide as a prototype.

Authors:  Ritesh K Srivastava; Changzhao Li; Zhiping Weng; Anupam Agarwal; Craig A Elmets; Farrukh Afaq; Mohammad Athar
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.